Randomized, Dose-finding Study of BF 2.649 5 [BF-2649, tiprolisant], 10 20 and 40 mg/d in Comparison to Placebo in Excessive Daytime Sleepiness in Parkinson's Disease Patients (PD).

Trial Profile

Randomized, Dose-finding Study of BF 2.649 5 [BF-2649, tiprolisant], 10 20 and 40 mg/d in Comparison to Placebo in Excessive Daytime Sleepiness in Parkinson's Disease Patients (PD).

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2012

At a glance

  • Drugs Pitolisant (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Aug 2009 Actual patient number (108) added as reported by ClinicalTrials.gov.
    • 12 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Aug 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top